Literature DB >> 22539844

A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.

Debolina Ghosh1, Kelsey R LeVault, Aaron J Barnett, Gregory J Brewer.   

Abstract

The brain depends on redox electrons from nicotinamide adenine dinucleotide (reduced form; NADH) to produce ATP and oxyradicals (reactive oxygen species [ROS]). Because ROS damage and mitochondrial dysregulation are prominent in aging and Alzheimer's disease (AD) and their relationship to the redox state is unclear, we wanted to know whether an oxidative redox shift precedes these markers and leads to macromolecular damage in a mouse model of AD. We used the 3xTg-AD mouse model, which displays cognitive deficits beginning at 4 months. Hippocampal/cortical neurons were isolated across the age span and cultured in common nutrients to control for possible hormonal and vascular differences. We found an increase of NAD(P)H levels and redox state in nontransgenic (non-Tg) neurons until middle age, followed by a decline in old age. The 3xTg-AD neurons maintained much lower resting NAD(P)H and redox states after 4 months, but the NADH regenerating capacity continuously declined with age beginning at 2 months. These redox characteristics were partially reversible with nicotinamide, a biosynthetic precursor of NAD+. Nicotinamide also protected against glutamate excitotoxicity. Compared with non-Tg neurons, 3xTg-AD neurons had more mitochondria/neuron and lower glutathione (GSH) levels that preceded age-related increases in ROS levels. These GSH deficits were again reversible with nicotinamide in 3xTg-AD neurons. Surprisingly, low macromolecular ROS damage was only elevated after 4 months in the 3xTg-AD neurons if antioxidants were removed. The present data suggest that a more oxidized redox state and a lower antioxidant GSH defense can be dissociated from neuronal ROS damage, changes that precede the onset of cognitive deficits in the 3xTg-AD model.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539844      PMCID: PMC3376759          DOI: 10.1523/JNEUROSCI.6192-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.

Authors:  Grace E Stutzmann; Ian Smith; Antonella Caccamo; Salvatore Oddo; Frank M Laferla; Ian Parker
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

2.  Isolation and culture of adult neurons and neurospheres.

Authors:  Gregory J Brewer; John R Torricelli
Journal:  Nat Protoc       Date:  2007       Impact factor: 13.491

3.  Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD.

Authors:  Tanea T Reed; William M Pierce; William R Markesbery; D Allan Butterfield
Journal:  Brain Res       Date:  2009-04-15       Impact factor: 3.252

4.  Isolation and culture of adult rat hippocampal neurons.

Authors:  G J Brewer
Journal:  J Neurosci Methods       Date:  1997-02       Impact factor: 2.390

Review 5.  Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations.

Authors:  Balaraman Kalyanaraman; Victor Darley-Usmar; Kelvin J A Davies; Phyllis A Dennery; Henry Jay Forman; Matthew B Grisham; Giovanni E Mann; Kevin Moore; L Jackson Roberts; Harry Ischiropoulos
Journal:  Free Radic Biol Med       Date:  2011-10-02       Impact factor: 7.376

6.  Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.

Authors:  Kim N Green; Joan S Steffan; Hilda Martinez-Coria; Xuemin Sun; Steven S Schreiber; Leslie Michels Thompson; Frank M LaFerla
Journal:  J Neurosci       Date:  2008-11-05       Impact factor: 6.167

7.  Nicotinamide adenine dinucleotide fluorescence spectroscopy and imaging of isolated cardiac myocytes.

Authors:  J Eng; R M Lynch; R S Balaban
Journal:  Biophys J       Date:  1989-04       Impact factor: 4.033

8.  Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice.

Authors:  José R Lopez; Alvin Lyckman; Salvatore Oddo; Frank M Laferla; Henry W Querfurth; Alexander Shtifman
Journal:  J Neurochem       Date:  2007-11-16       Impact factor: 5.372

9.  Age-related decreases in NAD(P)H and glutathione cause redox declines before ATP loss during glutamate treatment of hippocampal neurons.

Authors:  Mordhwaj S Parihar; Elizabeth A Kunz; Gregory J Brewer
Journal:  J Neurosci Res       Date:  2008-08-01       Impact factor: 4.164

10.  Age-related deficiencies in complex I endogenous substrate availability and reserve capacity of complex IV in cortical neuron electron transport.

Authors:  Torrie T Jones; Gregory J Brewer
Journal:  Biochim Biophys Acta       Date:  2009-09-30
View more
  57 in total

1.  Role of antioxidant enzymes in redox regulation of N-methyl-D-aspartate receptor function and memory in middle-aged rats.

Authors:  Wei-Hua Lee; Ashok Kumar; Asha Rani; Thomas C Foster
Journal:  Neurobiol Aging       Date:  2013-12-09       Impact factor: 4.673

2.  Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.

Authors:  Debolina Ghosh; Kelsey R LeVault; Gregory J Brewer
Journal:  Neurobiol Aging       Date:  2013-08-15       Impact factor: 4.673

3.  Linking redox regulation of NMDAR synaptic function to cognitive decline during aging.

Authors:  Ashok Kumar; Thomas C Foster
Journal:  J Neurosci       Date:  2013-10-02       Impact factor: 6.167

4.  Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.

Authors:  Robert J Pawlosky; Martin F Kemper; Yoshihero Kashiwaya; Michael Todd King; Mark P Mattson; Richard L Veech
Journal:  J Neurochem       Date:  2017-03-15       Impact factor: 5.372

5.  TPPU protects tau from H2O2-induced hyperphosphorylation in HEK293/tau cells by regulating PI3K/AKT/GSK-3β pathway.

Authors:  En-Sheng Yao; Yan Tang; Xing-Hua Liu; Ming-Huan Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

6.  Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession.

Authors:  Dong Liu; Michael Pitta; Haiyang Jiang; Jong-Hwan Lee; Guofeng Zhang; Xinzhi Chen; Elisa M Kawamoto; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2012-12-25       Impact factor: 4.673

7.  External cys/cySS redox state modification controls the intracellular redox state and neurodegeneration via Akt in aging and Alzheimer's disease mouse model neurons.

Authors:  Debolina Ghosh; Gregory J Brewer
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  Lenti-GDNF gene therapy protects against Alzheimer's disease-like neuropathology in 3xTg-AD mice and MC65 cells.

Authors:  Susana Revilla; Suzanna Ursulet; María Jesús Álvarez-López; Marco Castro-Freire; Unai Perpiñá; Yoelvis García-Mesa; Analía Bortolozzi; Lydia Giménez-Llort; Perla Kaliman; Rosa Cristòfol; Chamsy Sarkis; Coral Sanfeliu
Journal:  CNS Neurosci Ther       Date:  2014-08-13       Impact factor: 5.243

Review 9.  Antioxidant gene therapy against neuronal cell death.

Authors:  Juliana Navarro-Yepes; Laura Zavala-Flores; Annadurai Anandhan; Fang Wang; Maciej Skotak; Namas Chandra; Ming Li; Aglaia Pappa; Daniel Martinez-Fong; Luz Maria Del Razo; Betzabet Quintanilla-Vega; Rodrigo Franco
Journal:  Pharmacol Ther       Date:  2013-12-12       Impact factor: 12.310

10.  β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice.

Authors:  Clark A Briggs; Corinne Schneider; Jill C Richardson; Grace E Stutzmann
Journal:  Neurobiol Aging       Date:  2013-01-18       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.